Leslie Shaw to Paclitaxel
This is a "connection" page, showing publications Leslie Shaw has written about Paclitaxel.
Connection Strength
0.171
-
Mercado-Matos J, Clark JL, Piper AJ, Janusis J, Shaw LM. Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells. J Biol Chem. 2017 05 12; 292(19):7806-7816.
Score: 0.133
-
Huang K, Vaughn DJ, Shaw LM, Recio A, Bonner HS, Haller DG. A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer. Am J Clin Oncol. 1998 Dec; 21(6):548-52.
Score: 0.037